Clinical trials of biologics

The group has a fully staffed clinical trials unit that is world leading in studies of new targeted biological therapies for psoriasis including:

  • TNF antagonists
  • T cell activation blockers
  • IL-12/IL-23 antagonists

The unit was established in 1994 and is one of Europe's leading dermatology clinical trials units.

Study volunteers/patients

We are always looking for volunteers with psoriasis, and volunteers with no active skin conditions to participate in clinical trials. For more information visit our Skin Research website.